Oxazinanes
![Aobchem 3 4-Dihydro-2H-benzo[b][1 4]dioxepine-7-carbaldehyde | ≥95% | CAS 67869-90-3 | C10H10O3 | 10g](https://assets.fishersci.com/TFS-Assets/CCG/product-images/default.jpg-250.jpg)
Aobchem 3 4-Dihydro-2H-benzo[b][1 4]dioxepine-7-carbaldehyde | ≥95% | CAS 67869-90-3 | C10H10O3 | 10g
3 4-Dihydro-2H-benzo[b][1 4]dioxepine-7-carbaldehyde | ≥95% | CAS 67869-90-3 | C10H10O3 | 10g
Aobchem 6-Bromo-5-fluoro-2-methyl-2H-indazole | ≥95% | CAS 1286734-87-9 | C8H6BrFN2 | 10g
6-Bromo-5-fluoro-2-methyl-2H-indazole | ≥95% | CAS 1286734-87-9 | C8H6BrFN2 | 10g
Aobchem (5-Ethylbenzofuran-2-yl)boronic acid | 97% | CAS 1450790-30-3 | C10H11BO3 | 1g
(5-Ethylbenzofuran-2-yl)boronic acid | 97% | CAS 1450790-30-3 | C10H11BO3 | 1g
Aobchem 1-(3-Chloro-5-morpholinophenyl)propan-1-one | 95% | C13H16ClNO2 | 1g
1-(3-Chloro-5-morpholinophenyl)propan-1-one | 95% | C13H16ClNO2 | 1g
Aobchem 5 8-Dibromo-2 3-dihydro-1 4-benzodioxin | 97% | CAS 2385024-17-7 | C8H6Br2O2 | 5g
5 8-Dibromo-2 3-dihydro-1 4-benzodioxin | 97% | CAS 2385024-17-7 | C8H6Br2O2 | 5g
Aobchem 5-Methyl-2-(4-nitrophenoxy)benzaldehyde | 95% | CAS 1991821-86-3 | C14H11NO4 | 5g
5-Methyl-2-(4-nitrophenoxy)benzaldehyde | 95% | CAS 1991821-86-3 | C14H11NO4 | 5g
Aobchem (2 4-Difluorophenyl)(morpholino)methanone | 97% | CAS 948717-49-5 | C11H11F2NO2 | 500mg
(2 4-Difluorophenyl)(morpholino)methanone | 97% | CAS 948717-49-5 | C11H11F2NO2 | 500mg
Aobchem 1-(4-Benzoylphenyl)ethanone | 95% | CAS 53689-84-2 | C15H12O2 | 250mg
1-(4-Benzoylphenyl)ethanone | 95% | CAS 53689-84-2 | C15H12O2 | 250mg
Aobchem 4 5-Dichloro-2-methyl-2H-1 2 3-triazole | 95% | C3H3Cl2N3 | 1g
4 5-Dichloro-2-methyl-2H-1 2 3-triazole | 95% | C3H3Cl2N3 | 1g
Cayman Chemical Cl-Amidine (hydrochloride), Purity: ≥95%, CAS: 1373232-26-8, 1 mg
A PAD inhibitor (IC50s = 0.8, 6.2, and 5.9 µM for PAD1, PAD3, and PAD4, respectively); cytotoxic to HL-60, MCF-7, and HT-29 cancer cells (IC50s = 0.25, 0.05, and 1 μM, respectively); reduces ex vivo extracellular NET formation and increases survival in a mouse model of CLP-induced sepsis at 50 mg/kg; decreases the citrulline content in serum and joints and reduces the development of IgG autoantibodies in a mouse model of collagen-induced arthritis
Cayman Chemical CP 24,879 (hydrochloride), Purity: ≥98%, CAS: 10141-51-2, 5 mg
A Δ5/Δ6 desaturase inhibitor; reduces liver arachidonate content by ~50% in mice at 3 mg/kg; increases mead acid content and inhibits leukotriene C4 synthesis in murine mastocytoma cells at 5 µM